uMed
With Cloud Gateway’s HSCN connectivity live in two weeks, uMed connected over 125 UK health practices to its clinical research platform at launch – enabling regulatory-grade studies to run simultaneously at scale, and supporting Oxford University Hospitals as part of a national Covid-19 research programme. The platform has since grown to over 500 practices, representing five million patients across the UK and US.
125 UK health practices connected at launch,
now scaled to 500 - HSCN live in two weeks
patients successfully recruited to clinical studies across the network.
The challenge
uMed is a technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolised patient registries. The platform enables sites to participate in dozens of programmes simultaneously without increasing overhead on staff.
Before uMed, clinical research execution was overwhelmingly manual. GPs and surgery staff were responsible for identifying patients, engaging them in studies, collecting and structuring data, and returning it to the researching organisation. The volume of manual input meant GPs could typically only participate in one or two studies at any one time – slowing down research outputs and limiting patient access to clinical trials.
uMed’s platform, built in AWS, needed access to health record data via agreements with the major health record providers. The only compliant route for transferring patient data was via the HSCN. uMed did not have an HSCN connection in place.
What we did
We set up a working proof of concept within minutes, using the Cloud Gateway platform. The full solution with HSCN connectivity was provisioned and onboarded in two weeks from first engagement, connecting uMed’s AWS-hosted platform to the partner health record providers.
Once live, uMed could manage the whole end-to-end downstream activity – connecting patients to clinical studies and securing consent faster, cutting physical activity required from GP surgeries, and giving practice staff time back to focus on patient care.
The impact
- HSCN connectivity provisioned and onboarded in two weeks from first engagement
- 125 UK health practices connected to the uMed platform at launch – since grown to over 500, representing five million patients across the UK and US
- Supporting Oxford University Hospitals as part of a national Covid-19 research programme
- Regulatory-grade clinical research studies running simultaneously across multiple therapeutic areas – up from the one or two studies GPs could previously support concurrently
- Over 6,000 patients successfully recruited to clinical studies across the network, with a consent rate exceeding 10% against an industry average of 3%
- Monthly randomised patients increased by an average of three times compared to manual recruitment methods
Connect. Protect. Observe. Assure. Automate.
Get your regulated connectivity right first time.